Edwards Lifesciences reported earnings of $ 0.80 per EW share on Nov 4, 2026, beating analysts' expectations by
| Report Date | Nov 4, 2026 |
|---|---|
| Forecasted EPS | $ 0.744 |
| Earnings Per Share (Surprise) | $ 0.80 (+$ 0.056) |
| Last Year's EPS | $ 0.64 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, Edwards Lifesciences beat analysts’ expectations 69 times and fell short of expectations 13 time(s). Edwards Lifesciences reported earnings per share of $ 0.80 in the last report surpassing an estimated EPS of $ 0.744 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 4, 2026 | $ 0.744 | $ 0.80 | $ 0.67 | |
| Jul 23, 2026 | $ 0.743 | $ 0.78 | $ 0.67 | |
| Apr 23, 2026 | $ 0.729 | $ 0.78 | $ 0.64 | |
| Feb 10, 2026 | $ 0.618 | $ 0.58 | $ 0.59 | |
| Oct 30, 2025 | $ 0.596 | $ 0.67 | $ 0.67 | |
| Jul 24, 2025 | $ 0.624 | $ 0.67 | $ 0.70 | |
| Apr 23, 2025 | $ 0.596 | $ 0.64 | $ 0.66 | |
| Feb 11, 2025 | $ 0.551 | $ 0.59 | $ 0.64 | |
| Oct 24, 2024 | $ 0.665 | $ 0.67 | $ 0.59 | |
| Jul 24, 2024 | $ 0.69 | $ 0.70 | $ 0.66 | |
| Apr 25, 2024 | $ 0.64 | $ 0.66 | $ 0.62 | |
| Feb 6, 2024 | $ 0.64 | $ 0.64 | $ 0.64 | |
| Oct 25, 2023 | $ 0.59 | $ 0.59 | $ 0.61 | |
| Jul 26, 2023 | $ 0.65 | $ 0.66 | $ 0.63 | |
| Apr 26, 2023 | $ 0.61 | $ 0.62 | $ 0.60 | |
| Jan 31, 2023 | $ 0.61 | $ 0.64 | $ 0.51 | |
| Oct 27, 2022 | $ 0.62 | $ 0.61 | $ 0.54 | |
| Jul 28, 2022 | $ 0.64 | $ 0.63 | $ 0.64 | |
| Apr 26, 2022 | $ 0.57 | $ 0.60 | $ 0.54 | |
| Jan 26, 2022 | $ 0.55 | $ 0.51 | $ 0.50 |
Edwards Lifesciences’s stock was trading at $ 95.19 on Nov 3, 2026 a day before the last earnings report was released.Following the release of the earnings report, EW’s price increased to $ 100.82 on Nov 5, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 4, 2026 | $ 0.80 | $ 95.19 | $ 100.82 | |
| Jul 23, 2026 | $ 0.78 | $ 84.37 | $ 82.63 | |
| Apr 23, 2026 | $ 0.78 | $ 81.53 | $ 84.15 | |
| Feb 10, 2026 | $ 0.58 | $ 76.80 | $ 79.33 | |
| Oct 30, 2025 | $ 0.67 | $ 82.69 | $ 82.45 | |
| Jul 24, 2025 | $ 0.67 | $ 76.91 | $ 80.00 | |
| Apr 23, 2025 | $ 0.64 | $ 70.60 | $ 75.13 | |
| Feb 11, 2025 | $ 0.59 | $ 71.10 | $ 75.82 | |
| Oct 24, 2024 | $ 0.67 | $ 70.61 | $ 69.38 | |
| Jul 24, 2024 | $ 0.70 | $ 87.05 | $ 59.70 | |
| Apr 25, 2024 | $ 0.66 | $ 88.61 | $ 86.43 | |
| Feb 6, 2024 | $ 0.64 | $ 86.06 | $ 86.61 | |
| Oct 25, 2023 | $ 0.59 | $ 70.49 | $ 62.78 | |
| Jul 26, 2023 | $ 0.66 | $ 91.68 | $ 82.67 | |
| Apr 26, 2023 | $ 0.62 | $ 87.77 | $ 86.72 | |
| Jan 31, 2023 | $ 0.64 | $ 76.06 | $ 81.48 | |
| Oct 27, 2022 | $ 0.61 | $ 86.76 | $ 70.87 | |
| Jul 28, 2022 | $ 0.63 | $ 105.61 | $ 100.54 | |
| Apr 26, 2022 | $ 0.60 | $ 119.80 | $ 109.80 | |
| Jan 26, 2022 | $ 0.51 | $ 109.49 | $ 101.96 |
Edwards Lifesciences released its most recent earnings reports in November 2026, July 2026, April 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Edwards Lifesciences beat analysts’ expectations during the last earnings period by
